Improving Public Cancer Care by Implementing Precision Medicine in Norway

NCT04817956 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

3000

Enrollment

OTHER

Sponsor class

Conditions

Cancer Metastatic

Interventions

DRUG: Atezolizumab

Sponsor

Oslo University Hospital

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]